You just read:

Synthetic Biologics Announces Detailed Data from Two SYN-010 Phase 2 Clinical Trials for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)

News provided by

Synthetic Biologics, Inc.

May 23, 2016, 06:50 ET